Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.72B | 9.84B | 8.95B | 7.52B | 7.09B | 6.26B |
Gross Profit | 3.73B | 3.92B | 3.41B | 3.15B | 2.98B | 2.46B |
EBITDA | 1.74B | 2.05B | 1.47B | 1.94B | 1.78B | 1.21B |
Net Income | 1.04B | 932.98M | 1.13B | 1.06B | 967.27M | 589.04M |
Balance Sheet | ||||||
Total Assets | 20.43B | 20.26B | 19.34B | 16.80B | 15.31B | 14.13B |
Cash, Cash Equivalents and Short-Term Investments | 3.84B | 3.86B | 3.14B | 2.46B | 2.88B | 2.55B |
Total Debt | 1.15B | 1.15B | 1.21B | 377.44M | 71.84M | 94.38M |
Total Liabilities | 3.48B | 3.29B | 3.55B | 2.32B | 2.13B | 1.87B |
Stockholders Equity | 16.80B | 16.82B | 15.65B | 14.40B | 13.11B | 12.19B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.18B | 1.06B | 155.87M | 371.19M | 1.03B |
Operating Cash Flow | 0.00 | 1.42B | 1.45B | 961.47M | 1.26B | 1.26B |
Investing Cash Flow | 0.00 | -396.26M | -1.08B | -1.59B | -801.79M | -850.64M |
Financing Cash Flow | 0.00 | -677.73M | 312.28M | -67.44M | -227.11M | -254.66M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥9.73B | 10.39 | 3.53% | 9.95% | -17.59% | ||
80 Outperform | ¥17.64B | 10.06 | 2.02% | 20.91% | 18.64% | ||
78 Outperform | ¥12.96B | 11.19 | 0.54% | 6.51% | 3.68% | ||
77 Outperform | ¥92.21B | 10.96 | 3.24% | -1.05% | -23.08% | ||
67 Neutral | €8.25B | 20.66 | 6.46% | 2.83% | 1.83% | -39.96% | |
51 Neutral | ¥5.62B | ― | 1.72% | 10.20% | -142.32% |